How to Buy Rapid Micro Biosystems Stock
Rapid Micro Biosystems Inc
Rapid Micro Biosystems, Inc. , a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia.
Rapid Micro Biosystems stock last closed at $2.30, up 1.32% from the previous day, and has increased 164.06% in one year. It has overperformed other stocks in the Medical Devices industry by 1.81 percentage points. Rapid Micro Biosystems stock is currently +296.55% from its 52-week low of $0.58, and -43.13% from its 52-week high of $4.04.
At the moment, there are 43.24M RPID shares outstanding. The market capitalization of RPID is $99.44M. In the last 24 hours, 170,032 RPID shares were traded.
How to Buy Rapid Micro Biosystems Stock
Not sure how to invest in Rapid Micro Biosystems stock? Here's how.
- Decide where to buy Rapid Micro Biosystems stock: You need to decide on an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you figure out where to buy Rapid Micro Biosystems stock.
- Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Fund your investment account: Pick your payment method and add your info.
- Research Rapid Micro Biosystems stock: The Rapid Micro Biosystems ticker symbol is RPID. Is Rapid Micro Biosystems stock a good investment? Should you buy shares of RPID? How do RPID's underlying business fundamentals look? Do top analysts think Rapid Micro Biosystems is a good buy? Why has RPID's stock price moved recently? (Hint: Our stock research tools can help you decide if RPID is a good stock to buy).
- Make your RPID buy order: Decide if you will purchase RPID shares at the current market price or use a limit order to buy RPID stock at a specific price.
- Watch your investment in RPID: Create a watchlist to watch your investment in Rapid Micro Biosystems shares.
Step 1: Decide where to buy Rapid Micro Biosystems stock
You will need an online brokerage account to access the NASDAQ market and buy RPID stock.
Our favorite brokerage: eToro
In our opinion, eToro is the best brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to global markets: From Technology to Real Estate, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've picked the best brokerage, the next step is to fill out some personal details so you can buy RPID stock today.
How to Open a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to create a new brokerage account.
- Send your data by pressing the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you have created your account on the greatest app to buy stocks, your next step is to transfer the money for your investment:
Check out the video below if you need help transferring funds into your investment account.
Step 4: Research Rapid Micro Biosystems stock
Once you have decided on the best place to buy Rapid Micro Biosystems stock, it's important to analyze their stock prior to buying, so you can comprehend the risk as well as the opportunity.
Rapid Micro Biosystems stock at a glance
RPID Overview
WallStreetZen was built to help everyday investors perform more in-depth fundamental analysis.
You can view all of the due diligence checks on RPID's stock page.
Is RPID stock undervalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge RPID's true value.
Using relative valuations methods:
- RPID may be undervalued based on its P/B ratio of 1.32x, relative to Medical Devices industry P/B ratio of 3.8x
You can do additional valuation analysis on RPID's stock here.
A quick look at RPID Financials
Signs that RPID is financially healthy:
- Total RPID debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than short-term liabilities on the RPID balance sheet.
- There are more short-term assets than long-term liabilities on the RPID balance sheet.
- RPID has cash burn of 45518000. It has enough cash and short-term investments to cover this for at least one year.
- RPID has $51.10M in cash and short term investments. This is sufficient to cover its annual cash burn of $45.52M.
- RPID has a low debt to equity ratio of 0.3.
Signs that RPID is not financially healthy:
- RPID profit margin has gone up by 0.66 percentage points in the past year, but the company is still unprofitable.
Do analysts think it's a good time to buy Rapid Micro Biosystems stock
Out of 1 Wall Street analysts who give ratings on RPID, the consensus analyst rating on RPID is a Strong Buy
Please note that analyst ratings are not stock recommendations, nor are they investment advice.
You can dig deeper into what analysts are projecting on the Rapid Micro Biosystems stock forecast page.
RPID Technical Indicators
Is RPID Growing Revenue?
Last year, RPID revenue was $28.05M. In the last five year, RPID's revenue has gone up by 11.18% per year. This was faster than the Medical Devices industry average of 9.81%.
You can analyze RPID's earnings and revenue performance here.
Who is buying/selling RPID?
Over the last 12 months, executives and large shareholders at RPID have bought more shares than they have sold.
Robert G. Spignesi Jr., PRESIDENT AND CEO of RPID, was the latest RPID insider to sell. They sold $25,453.50 worth of RPID stock on Mar 9, 2025.
Research more about who owns RPID shares here.
Can I rely on RPID as an income stream?
No, Rapid Micro Biosystems doesn't provide an income stream by paying out dividends.
Get opinions from other traders
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Make your RPID buy order
There are two main types of orders:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are mostly the best for newer investors. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a given price limit, place a limit order.
Hit the Open button and your broker will execute your order.
If you want more info about investing in stocks on eToro, click the how to video below:
Step 6: Watch your investment in RPID
Now that you own some RPID stock, you'll want to keep up with your stock purchase.
Make a watchlist to get notified of the latest news about your RPID stock.
RPID Feed
How to Buy Stock in Rapid Micro Biosystems
To summarize, here are the 6 steps for buying Rapid Micro Biosystems stock:
- Decide where to buy Rapid Micro Biosystems stock
- Open a brokerage account
- Fund your investment account
- Research Rapid Micro Biosystems stock
- Make your RPID buy order
- Watch your investment in RPID
If you require a place to buy stocks, eToro is our recommended option.
Get Started with eToro TodayIf you would like to keep an eye on your investment in Rapid Micro Biosystems, add RPID to your watchlist below.
More Articles You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.